Return On Assets of Arbutus Biopharma Corp from 30 Sep 2014 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Arbutus Biopharma Corp quarterly and annual Return On Assets in % history and change rate from 30 Sep 2014 to 30 Sep 2025.
  • Arbutus Biopharma Corp Return On Assets for the quarter ending 30 Sep 2025 was -38%, a 27% increase year-over-year.
  • Arbutus Biopharma Corp annual Return On Assets for 2024 was -48%, a 11% decline from 2023.
  • Arbutus Biopharma Corp annual Return On Assets for 2023 was -43%, a 33% decline from 2022.
  • Arbutus Biopharma Corp annual Return On Assets for 2022 was -33%, a 30% increase from 2021.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Change (%)
Return On Assets, Annual (%)
Return On Assets, YoY Annual Change (%)

Arbutus Biopharma Corp Quarterly Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 -38% +14% +27% 01 Jul 2025 30 Sep 2025
Q2 2025 -44% +6.2% +12% 01 Apr 2025 30 Jun 2025
Q1 2025 -56% -8.6% -18% 01 Jan 2025 31 Mar 2025
Q4 2024 -48% -4.6% -11% 01 Oct 2024 31 Dec 2024
Q3 2024 -52% -9.7% -23% 01 Jul 2024 30 Sep 2024
Q2 2024 -50% -12% -32% 01 Apr 2024 30 Jun 2024
Q1 2024 -47% -12% -36% 01 Jan 2024 31 Mar 2024
Q4 2023 -43% -11% -33% 01 Oct 2023 31 Dec 2023
Q3 2023 -42% -9.8% -31% 01 Jul 2023 30 Sep 2023
Q2 2023 -38% -3.8% -11% 01 Apr 2023 30 Jun 2023
Q1 2023 -35% +6% +15% 01 Jan 2023 31 Mar 2023
Q4 2022 -33% +14% +30% 01 Oct 2022 31 Dec 2022
Q3 2022 -32% +17% +35% 01 Jul 2022 30 Sep 2022
Q2 2022 -34% +18% +34% 01 Apr 2022 30 Jun 2022
Q1 2022 -41% +11% +21% 01 Jan 2022 31 Mar 2022
Q4 2021 -47% +7.6% +14% 01 Oct 2021 31 Dec 2021
Q3 2021 -49% +16% +25% 01 Jul 2021 30 Sep 2021
Q2 2021 -52% +76% +59% 01 Apr 2021 30 Jun 2021
Q1 2021 -52% +60% +54% 01 Jan 2021 31 Mar 2021
Q4 2020 -54% +44% +45% 01 Oct 2020 31 Dec 2020
Q3 2020 -65% +14% +17% 01 Jul 2020 30 Sep 2020
Q2 2020 -128% -87% -213% 01 Apr 2020 30 Jun 2020
Q1 2020 -111% -85% -325% 01 Jan 2020 31 Mar 2020
Q4 2019 -98% -76% -340% 01 Oct 2019 31 Dec 2019
Q3 2019 -79% -50% -172% 01 Jul 2019 30 Sep 2019
Q2 2019 -41% -17% -69% 01 Apr 2019 30 Jun 2019
Q1 2019 -26% +7% +21% 01 Jan 2019 31 Mar 2019
Q4 2018 -22% +11% +34% 01 Oct 2018 31 Dec 2018
Q3 2018 -29% +74% +72% 01 Jul 2018 30 Sep 2018
Q2 2018 -24% +60% +71% 01 Apr 2018 30 Jun 2018
Q1 2018 -33% +64% +66% 01 Jan 2018 31 Mar 2018
Q4 2017 -34% +42% +56% 01 Oct 2017 31 Dec 2017
Q3 2017 -103% -75% -271% 01 Jul 2017 30 Sep 2017
Q2 2017 -84% -57% -210% 01 Apr 2017 30 Jun 2017
Q1 2017 -97% -88% -990% 01 Jan 2017 31 Mar 2017
Q4 2016 -76% -68% -830% 01 Oct 2016 31 Dec 2016
Q3 2016 -28% -17% -169% 01 Jul 2016 30 Sep 2016
Q2 2016 -27% -18% -192% 01 Apr 2016 30 Jun 2016
Q1 2016 -8.9% +2.4% +21% 01 Jan 2016 31 Mar 2016
Q4 2015 -8.2% +22% +73% 01 Oct 2015 31 Dec 2015
Q3 2015 -10% +20% +66% 01 Jul 2015 30 Sep 2015
Q2 2015 -9.2% 01 Apr 2015 30 Jun 2015
Q1 2015 -11% 01 Jan 2015 31 Mar 2015
Q4 2014 -30% 01 Oct 2014 31 Dec 2014
Q3 2014 -30% 01 Jul 2014 30 Sep 2014

Arbutus Biopharma Corp Annual Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
2024 -48% -4.6% -11% 01 Jan 2024 31 Dec 2024
2023 -43% -11% -33% 01 Jan 2023 31 Dec 2023
2022 -33% +14% +30% 01 Jan 2022 31 Dec 2022
2021 -47% +7.6% +14% 01 Jan 2021 31 Dec 2021
2020 -54% +44% +45% 01 Jan 2020 31 Dec 2020
2019 -98% -76% -340% 01 Jan 2019 31 Dec 2019
2018 -22% +11% +34% 01 Jan 2018 31 Dec 2018
2017 -34% +42% +56% 01 Jan 2017 31 Dec 2017
2016 -76% -68% -806% 01 Jan 2016 31 Dec 2016
2015 -8.4% +22% +72% 01 Jan 2015 31 Dec 2015
2014 -30% 01 Jan 2014 31 Dec 2014
* An asterisk sign (*) next to the value indicates that the value is likely invalid.